Hypertension, Pulmonary
161
4
8
109
Key Insights
Highlights
Success Rate
84% trial completion
Published Results
36 trials with published results (22%)
Research Maturity
109 completed trials (68% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
12.4%
20 terminated out of 161 trials
84.5%
-2.0% vs benchmark
28%
45 trials in Phase 3/4
33%
36 of 109 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 109 completed trials
Clinical Trials (161)
Study of Dehydroepiandrosterone (DHEA) in Respiratory Pulmonary Hypertension in Adults (DHEA-HTAP)
Study of Dehydroepiandrosterone (DHEA) in Respiratory Pulmonary Hypertension in Adults
Extension Study of Sotatercept in People With Pulmonary Hypertension (MK-7962-023)
A Study of Selexipag as Add-On Treatment to Standard of Care in Children With Pulmonary Arterial Hypertension
A Study Providing Treatment Access in Participants With Pulmonary Hypertension Completing a Parent Study and Having no Other Option
Pulmonary Artery Remodelling With Bosentan
Riociguat in Children With Pulmonary Arterial Hypertension (PAH)
Inflammatory Biomarkers of Pediatric Pulmonary Hypertension
A Study of Sotatercept for the Treatment of Cpc-PH Due to HFpEF (MK-7962-007/A011-16)
A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients
Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease
A Deep-Learning-Enabled Electrocardiogram for Detecting Pulmonary Hypertension
A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
A Long-term Extension Study of Riociguat in Patients With Symptomatic Pulmonary Arterial Hypertension.
Functional Pulmonary Capillary Surface Area in BPA for CTEPH
A Study for the Identification of Biomarker Signatures for Early Detection of Pulmonary Hypertension (PH)
A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction
Impact of Multiple Doses of BAY63-2521 on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Patients With Interstitial Lung Disease (ILD) Associated Pulmonary Hypertension (PH)
Deep Learning Detection of Pulmonary Hypertension and Low Ejection Fraction Via Digital Stethoscope and 3-Lead ECG
Treatment of Pulmonary Hypertension in High-risk Cardiac Surgery Patients Using Inhalational and Intravenous Agents